Welcome to our dedicated page for Barrick Mining Corporation news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barrick Mining Corporation stock.
The Barrick Mining Corporation (NYSE: B, TSX: ABX) news page on Stock Titan provides a focused view of company announcements and market-facing disclosures for one of the world’s largest gold miners. Barrick’s news flow reflects its role as a major producer of gold and copper, with operations and projects across the Americas, Africa, the Middle East, and Asia.
Investors following B stock can use this page to track key corporate updates that shape the company’s outlook. These include notices about upcoming earnings releases and webcasts, such as the announcement that Barrick will report its full year and fourth quarter 2025 results on February 5, 2026, with a live webcast and analyst question-and-answer session. Such events offer insight into production performance, costs, project progress, and capital allocation decisions.
Alongside earnings-related news, Barrick’s regulatory communications often appear in the form of press releases furnished with its Form 6-K filings. These may cover quarterly results, comparative unaudited financial statements prepared in accordance with International Financial Reporting Standards, management’s discussion and analysis, and capital management actions such as share buyback programs.
By reviewing the Barrick Mining Corporation news feed, readers can monitor how the company reports on its gold and copper production profile, reserve base, and key projects like the Lumwana expansion and the Reko Diq copper and gold development. Bookmark this page to quickly access the latest Barrick announcements, scheduled results dates, and other official disclosures that inform analysis of the B stock.
BioArctic AB (Nasdaq Stockholm: BIOA B) announced that its partner Eisai will present significant new data on Leqembi® (lecanemab) at the upcoming Alzheimer's Association International Conference (AAIC) in Toronto from July 27-31, 2025.
Key presentations include four-year efficacy and safety data from the Phase 3 Clarity AD Open-Label Extension trial, new data on a subcutaneous formulation for maintenance dosing, and real-world case studies from U.S. clinical settings. Additionally, findings from cerebrospinal fluid samples using a novel immunoassay for measuring Aβ protofibrils will be presented.
Eisai leads the global development and regulatory submissions for Leqembi, with both Eisai and Biogen co-commercializing the product. BioArctic maintains commercialization rights in the Nordic region in partnership with Eisai.
Hexagon (HEXA) and Management Controls Inc. (MCi) have officially launched their integrated EcoSys + myTrack solution, combining Hexagon's EcoSys platform with MCi's myTrack platform. The integration aims to transform the management of shutdowns, turnarounds, and outages (STO) and capital projects.
The solution provides real-time cost and progress visibility by automating the collection and validation of contractor labor, equipment, and material data from the field. Key features include daily actuals tracking, SPI/CPI metrics within hours of shift completion, real-time vendor performance monitoring, and full alignment across scheduling and ERP systems.
The integrated solution, developed with FTI Consulting's implementation expertise, was initially unveiled at Hexagon LIVE Global 2025 in Las Vegas, targeting industries such as energy, chemicals, construction, and manufacturing.
Barrick Mining Corporation (NYSE:B) has announced it will release its Q2 2025 financial results on Monday, August 11, 2025, before market open at approximately 6:00 AM EDT. The company's President and CEO Mark Bristow will host a live presentation and webcast at 11:00 AM EDT, which will include a Q&A session with analysts.
The presentation materials will be accessible on Barrick's website, and the webinar recording will be available for later viewing.
BioArctic AB (Nasdaq Stockholm: BIOA B) announced that its partner Eisai has received the 9th Bioindustry Award from the Japan Bioindustry Association for the drug discovery research of lecanemab (Leqembi®), an antibody treatment for early Alzheimer's disease.
The treatment, co-developed by BioArctic and Eisai, is based on Professor Lars Lannfelt's discoveries about amyloid-beta protein's role in Alzheimer's disease. Lecanemab works by binding to specific forms of amyloid-beta and helping clear it from the brain. Eisai leads the global development and regulatory submissions, with both Eisai and Biogen handling commercialization. BioArctic retains commercialization rights in the Nordic region in partnership with Eisai.
Hexagon US Federal (HEXA) has announced the divestiture of its Strategic Services & Solutions (HS3) business to Bart & Associates (B&A), as initially disclosed on July 2, 2025. This strategic move aims to streamline operations and sharpen focus on the company's core technology offerings.
The company will concentrate on delivering cutting-edge software, hardware, and value-added products supporting defense, intelligence, and federal-civilian missions across public safety, geospatial-intelligence, sensors & systems, and position, navigation, and timing (PNT). The HS3 business, known for providing IT services, geospatial services, and integrated solutions, will continue its federal government support under B&A's ownership.
Barrick Mining Corporation (NYSE:B) is advancing its $2 billion Super Pit Expansion Project at the Lumwana mine in Zambia, transforming it into a Tier One copper mine. The expansion will double copper production to 240,000 tonnes annually, supported by a 50 million tonne per annum processing plant.
Since 2019, Lumwana has contributed over $4 billion to Zambia's economy through taxes, royalties, procurement, and wages, with 79% ($3.4 billion) spent with local suppliers. The project includes development of Manyama township, an industrial supplier park, and a new regional airstrip. The mine employs 98% Zambian nationals and is implementing a REDD+ forest conservation program covering 300,000 hectares.
The operation is tracking well against its 2025 production guidance, with strong Q1 performance driven by increased plant throughput and improved open-pit efficiency.
SimScale and Hexagon (HEXA) have announced the general availability of Marc nonlinear finite element analysis (FEA) solver technology on the SimScale cloud platform. This integration allows engineers and design teams to access Marc's advanced nonlinear simulation capabilities directly through web browsers.
The cloud-native solution offers key features including fast nonlinear analysis, real-time collaboration, AI-powered workflows, High Performance Computing (HPC) scalability, and comprehensive multi-physics coverage. The technology is immediately available to SimScale's 700,000 Community users for limited free, non-commercial testing.
Barrick Mining Corporation (NYSE:B) celebrates five years of its Twiga partnership with the Tanzanian government, demonstrating significant achievements in sustainable mining development. The company has injected $4.79 billion into Tanzania's economy, including $558 million in H1 2025.
Key operational highlights include over 90% procurement from Tanzanian suppliers and a 96% Tanzanian workforce. The partnership launched a $30 million Future Forward education programme with the government, expanding school infrastructure to accommodate 45,000 additional pupils. Both Bulyanhulu and North Mara mines are performing as planned, with significant infrastructure improvements and exploration activities targeting resource extensions.
Barrick Mining (NYSE:B) reports significant progress at Kibali, Africa's largest gold mine, with promising drilling results from the ARK-KCD corridor indicating potential for substantial reserve growth. The mine has surpassed $6.3 billion in DRC investment, including $3.1 billion to local contractors.
Operational highlights include the completion of a 16MW solar plant with Battery Energy Storage System, pushing renewable energy usage to 85%. The mine operates on 100% renewable energy for six months annually. The company is also advancing biodiversity initiatives, planning to introduce 64 additional white rhinos to Garamba National Park.
Community development continues with 41 of 44 projects completed through the 0.3% development fund, while $4.8 million has been invested in Cahier des Charges execution. The mine supports over 700 Congolese companies through procurement and capacity-building initiatives.
BioArctic (NASDAQ Stockholm: BIOA B) announced that its founder, Professor Lars Lannfelt, will receive the prestigious 2025 Hartwig Piepenbrock-DZNE Prize for his pioneering work in Alzheimer's disease research and the development of lecanemab.
Professor Lannfelt, who founded BioArctic in 2003 with Pär Gellerfors, made groundbreaking discoveries about the role of amyloid-beta protein in Alzheimer's disease. These findings led to the development of lecanemab, an antibody treatment that targets specific forms of amyloid-beta in the brain, developed in collaboration with Eisai. The treatment showed positive results in the global Phase 3 Clarity AD trial.
The award ceremony will take place in Bonn in November 2025. The prize, awarded biennially since 2011, recognizes outstanding research in neurodegenerative disorders.